Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine

The Middle East respiratory syndrome (MERS) is a respiratory disease caused by MERS coronavirus (MERS-CoV). In follow up to a phase 1 trial, we perform a longitudinal analysis of immune responses following immunization with the modified vaccinia virus Ankara (MVA)-based vaccine MVA-MERS-S encoding t...

Descripción completa

Detalles Bibliográficos
Autores principales: Weskamm, Leonie M., Fathi, Anahita, Raadsen, Matthijs P., Mykytyn, Anna Z., Koch, Till, Spohn, Michael, Friedrich, Monika, Haagmans, Bart L., Becker, Stephan, Sutter, Gerd, Dahlke, Christine, Addo, Marylyn M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295383/
https://www.ncbi.nlm.nih.gov/pubmed/35858586
http://dx.doi.org/10.1016/j.xcrm.2022.100685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295383/
https://www.ncbi.nlm.nih.gov/pubmed/35858586
http://dx.doi.org/10.1016/j.xcrm.2022.100685

Ejemplares similares